|
Oct 4
|
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
|
|
Jun 20
|
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
|
May 2
|
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
|
|
Apr 24
|
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
|
|
Apr 8
|
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
|
|
Apr 4
|
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
|
|
Apr 2
|
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 27
|
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
|
|
Mar 23
|
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
|
|
Mar 21
|
NextCure to lay off 37% of staff, dial back research plans
|
|
Mar 21
|
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
|
|
Mar 5
|
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
|
|
Dec 21
|
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
|
|
Nov 7
|
All You Need to Know About NextCure, Inc. (NXTC) Rating Upgrade to Buy
|
|
Nov 2
|
NextCure Inc (NXTC) Reports Q3 2023 Financial Results
|
|
Nov 2
|
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
|
|
Sep 26
|
NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease
|